I. Introduction
High-performance bio-potential signal acquisition requires sufficient rejection of common-mode interference and electrode dc offset (EDO) [1]–[3]. Taking the electroencephalography (EEG) as an example, the 5–300- signal comes often with large in-band common-mode interference, e.g., hundreds mV from 50-/60-Hz power lines, resulting in a 60–90-dB common-mode rejection ratio (CMRR) requirement. Clinical EEG has even higher CMRR requirement, e.g., 110 dB, as regulated by the International Federation of Clinical Neurophysiology (IFCN) [4]. Moreover, the electrochemical reaction in the electrode–tissue interface introduces EDO which can be as large as 300 mV, resulting in a 600-mV differential EDO in the worst case. The front-end instrumentation amplifiers (IAs) have to accommodate the design challenges of high CMRR and EDO rejection concurrently.